IVI RMA North America Partners with Illume Fertility, Establishing New Presence in Connecticut

HARTFORD, Conn., Sept. 8, 2026 /PRNewswire/ -- IVI RMA, the global leader in fertility care, today announced its partnership with Illume Fertility, the leading fertility group in Connecticut. Illume Fertility delivers exceptional patient care and success rates through its network of five locations in Connecticut and New York, strengthening IVI RMA North America's presence and reinforcing its commitment to delivering world-class fertility care.

"We're excited to welcome Illume Fertility to the IVI RMA North America family," said Lynn Mason, Chief Executive Officer of IVI RMA North America. "Illume's reputation for clinical excellence, innovative treatment protocols, and exceptional patient care aligns perfectly with our mission to expand access to top-notch fertility services. This partnership will help us better serve patients throughout the Northeast while maintaining the highest standards of care across our network."

"Joining IVI RMA North America marks an exciting next chapter for Illume Fertility," said Dr. Mark Leondires, Medical Director of Illume Fertility. "Our team has always been deeply committed to providing exceptional, holistic, inclusive care to every patient. Partnering with IVI RMA allows us to continue on our mission while giving our patients and the entire Illume team access to a broader network of clinical services, research, and innovation. We are all excited about what this means for the future of Illume and for the families we have the privilege of serving."

"We welcome Illume Fertility's talented team and their patients into the IVI RMA North America family, bringing excellent fertility care and expertise to an expanded network across Connecticut," said Dr. Thomas Molinaro, Chief Medical Officer. "This new partnership means more patients can benefit from our cutting-edge science and innovation and receive the personalized, individualized care we strive to provide. We look forward to expanding the possibilities for those seeking to build their families in Connecticut."

Illume Fertility's clinical team includes nine highly experienced fertility specialists, all board-certified in reproductive endocrinology and infertility as well as obstetrics and gynecology. These reproductive endocrinologists bring specialized fellowship training and expertise in fertility treatment, hormone regulation, and assisted conception—positioning the clinic among the region's most accomplished fertility providers.

This partnership advances IVI RMA's goal of bringing world class science, innovation, and fertility care to more communities nationwide. By establishing a strong presence in Connecticut, it further connects leading fertility practices across the Northeast, building a more integrated regional network that links our established operations in Boston and New Jersey. Together, these practices create greater access to the best fertility care across the region, enabling patients to benefit from IVI RMA's depth of expertise, advanced science, and collaborative care.

About IVI RMA North America

IVI RMA North America, comprising Reproductive Medicine Associates, Boston IVF, and Toronto-based TRIO, spans 27 IVF laboratories, resulting in the birth of over 11,000 babies in 2025. Pioneers in innovative care, including PGT-A, single embryo transfer, fertility preservation, LGBTQ+ care, and more, the network has published over 1,000 papers which have pushed the fertility industry forward. IVI RMA North America is part of IVI RMA Global, the world's leading Reproductive Medicine group committed to providing evidence-based fertility solutions to patients seeking treatment anywhere in the world. IVI RMA Global employs more than 6,000 people across 200+ locations in 15 countries. Learn more at rmanetwork.com and ivirma.com.

About Illume Fertility

Illume Fertility is a leading fertility practice serving patients across Connecticut and the surrounding region. Illume provides comprehensive reproductive medicine services including IVF, fertility preservation, donor and third-party reproduction, and advanced reproductive technologies, with a focus on compassionate, individualized patient care.

SOURCE IVI RMA